Online citations, reference lists, and bibliographies.
← Back to Search

Botulinum Toxin Treatment In Patients With Hemifacial Spasm

R. Laskawi, M. Ellies, C. Drobik, A. Baetz
Published 2004 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Hemifacial spasm is nearly always a unilateral disease of the facial musculature and is characterized by involuntary tonic or clonic cramps that considerably reduce the affected patient's quality of life. In the past, a number of different conservative and operative therapeutic procedures have been applied for the treatment of hemifacial spasm. In many cases these attempts failed to control the disease permanently or resulted in unwanted, sometimes strong, side effects. We report our own experiences with botulinum therapy in 29 patients with hemifacial spasm (78 therapeutic sessions). In our patients the mean duration of an effect after treatment with botulinum toxin was 18.2 weeks. Side effects were rare. Our results since 1990 at the University of Göttingen demonstrate that subcutaneous application of toxin from Clostridium botulinum to involved facial muscles represents a reliable method for successful treatment of hemifacial spasm.
This paper references
[Botulinum toxin in therapy of craniocervical dystonia].
D. Dressler (1989)
Microsurgical exploration and decompression of the facial nerve in hemifacial spasm
PJ Jannetta (1970)
Die Behandlung des Spasmus hemifacialis mit BotulinumToxin
H Schnyder (1992)
G. Proud (1953)
Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients.
P. Jannetta (1977)
Therapie des essentiellen Blepharospasmus und hemifacialen Spasmus mit lokalen Injektionen von Botulinum Toxin Typ A: Erfahrungen an 50 Patienten
W. Poewe (1989)
[Local injection treatment with botulinum toxin A in blepharospasm, Meige syndrome and hemifacial spasm. Observations in 106 patients].
A. Ceballos-Baumann (1990)
Botulinum toxin injection therapy for hemifacial spasm.
E. Tolosa (1988)
Botulinum toxin treatment of hemifacial spasm.
J. Elston (1986)
Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin.
J. Mauriello (1985)
Myectomy for essential blepharospasm.
T. Jones (1985)
Botulinum toxin in the management of blepharospasm.
J. Dutton (1986)
Carbamazepine for hemi facial spasm
G. E. Alexander (1982)
Botulinum Toxin in der Therapie kraniozervikaler Dystonien
D Dressier (1989)
Lokale Injektionsbehandlung mit BotulinumToxin A bei Blepharospasmus , MeigeSyndrom und Spasmus hemifacialis
AO Ceballos-Baumann (1990)
Eletrophysiological investigations in patients with hemifacial spasm
R Laskawi (1990)
Lokale Therapie mit Botulinum Toxin A bei fokalen Dystönien
R. Dengler (1990)
Botulinum A toxin for cranial‐cervical dystonia
J. Jankovic (1987)
Local side effects of botulinum toxin injections.
J. Patrinely (1988)
Hemifacial spasm: differential diagnosis, mechanism, and treatment.
K. Digre (1988)
Carbamazepine for hemifacial spasm.
G. E. Alexander (1982)
Hemifacial spasm. Comparison of three different operative procedures in 110 patients.
T. Iwakuma (1982)
Treatment of tic douloureux and hemifacial spasm by posterior fossa exploration: therapeutic implications of various neurovascular relationships.
J. Piatt (1984)
Blepharospasm, Meige syndronfie, and hemifacial Spasm
J. Mauriello (1985)
Hemifacial spasm treated with botulinum A toxin injection.
P. Savino (1985)
Botulinum toxin injection of eye muscles to correct strabismus.
A. B. Scott (1981)

This paper is referenced by
Surgical and conservative methods for restoring impaired motor function - facial nerve, spinal accessory nerve, hypoglossal nerve (not including vagal nerve or swallowing)
R. Laskawi (2005)
Can the Jankovic-assessment be used as an alternative to electromyography? A cross-sectional study on facial dystonia patients treated with Botulinum toxin.
A. Di Stadio (2019)
Neuronal Nitric Oxide Synthase-Immunoreactivity
S. Rohrbach (2002)
Costs of Treating Dystonias and Hemifacial Spasm with Botulinum Toxin A
R. Dodel (2012)
Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy
E. D. Toffola (2010)
Guidelines for the therapeutic use of botulinum toxin in movement disorders
A. Berardelli (2005)
Reduction of Salivary Flow With Botulinum Toxin: Extended Report on 33 Patients with Drooling, Salivary Fistulas, and Sialadenitis
M. Ellies (2004)
Management of Frey's syndrome and hypersialorrhea with botulinum toxin.
O. Guntinas-Lichius (2003)
Histopathological and radiological investigations of the influence of botulinum toxin on the submandibular gland of the rat
Berna Uslu Coskun (2007)
[Treatment of laryngeal movement disorders with botulinum toxins: part 1: History and mode of action].
C. Schwemmle (2007)
Die Anwendung von Botulinumtoxin in der HNO-Heilkunde
S. Rohrbach (2005)
Praktische Anwendung von Botulinumtoxin im Kopf-Hals-Bereich
K. Seifert (2004)
Botulinum Toxin Type a Induces Apoptosis in Nasal Glands of Guinea Pigs
S. Rohrbach (2001)
Increased Botulinum Toxin Type A Dosage Is More Effective in Patients With Frey's Syndrome
O. Guntinas-Lichius (2002)
Praktische Anwendung von Botulinumtoxin im Kopf-Hals-Bereich
S. Rohrbach (2004)
Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies.
M. Ellies (2003)
Botulinum toxin injections for the treatment of hemifacial spasm over 16years
M. Sorgun (2015)
Die Behandlung laryngealer Bewegungsstörungen mit Botulinumtoxinen
C. Schwemmle (2007)
[Changes in dose and injection pattern in the botulinum toxin long-term therapy of facial dyskinesis].
R. Laskawi (2014)
Semantic Scholar Logo Some data provided by SemanticScholar